Segment Information by Division

For the Period January 1 to December 31

2014

  Download XLS

 

  

 

€ million

  

Silicones

  

Polymers

  

Biosolutions

  

Polysilicon

  

Siltronic

  

Other

  

Consolidation

  

Group

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

External sales

  

1,733.3

  

1,040.5

  

176.2

  

949.5

  

848.0

  

78.9

  

–

  

4,826.4

Internal sales

  

0.3

  

23.9

  

–

  

99.6

  

5.4

  

87.0

  

-216.2

  

–

Total sales

  

1,733.6

  

1,064.4

  

176.2

  

1,049.1

  

853.4

  

165.9

  

-216.2

  

4,826.4

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

128.9

  

118.7

  

13.6

  

305.3

  

-43.5

  

-75.4

  

-4.3

  

443.3

Depreciation and impairments / write-ups

  

80.9

  

30.8

  

10.0

  

231.7

  

157.5

  

88.1

  

–

  

599.0

EBITDA

  

209.8

  

149.5

  

23.6

  

537.0

  

114.0

  

12.7

  

-4.3

  

1,042.3

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Result from investments in joint ventures and associates

  

2.9

  

–

  

–

  

–

  

–

  

–

  

–

  

2.9

Impairment losses

  

–

  

–

  

–

  

–

  

-9.5

  

–

  

–

  

-9.5

Additions to property, plant and equipment1

  

88.5

  

56.3

  

8.4

  

334.5

  

40.7

  

43.8

  

–

  

572.2

Asset additions

  

88.5

  

56.3

  

8.4

  

334.5

  

40.7

  

43.8

  

–

  

572.2

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,255.1

  

546.4

  

145.7

  

2,620.7

  

1,044.1

  

1,535.1

  

-199.9

  

6,947.2

Liabilities (Dec. 31)

  

762.1

  

297.9

  

75.2

  

1,623.9

  

758.8

  

1,668.0

  

-185.2

  

5,000.7

Net assets (Dec. 31)

  

493.0

  

248.5

  

70.5

  

996.8

  

285.3

  

-132.9

  

-14.7

  

1,946.5

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Investments in joint ventures and associates included in net assets (Dec. 31)

  

20.5

  

–

  

–

  

–

  

–

  

–

  

–

  

20.5

Research and development expenses

  

39.5

  

13.2

  

6.7

  

18.7

  

64.6

  

40.4

  

–

  

183.1

Employees (Dec. 31)

  

4,240

  

1,408

  

484

  

2,093

  

4,165

  

4,313

  

–

  

16,703

Employees (average)

  

4,201

  

1,400

  

476

  

2,083

  

4,263

  

4,321

  

–

  

16,744

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

2013

  Download XLS

 

  

 

€ million

  

Silicones

  

Polymers

  

Biosolutions

  

Polysilicon

  

Siltronic

  

Other

  

Consolidation

  

Group

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

External sales

  

1,672.0

  

958.3

  

158.4

  

844.9

  

735.8

  

109.5

  

–

  

4,478.9

Internal sales

  

0.2

  

20.4

  

–

  

79.3

  

7.2

  

83.2

  

-190.3

  

–

Total sales

  

1,672.2

  

978.7

  

158.4

  

924.2

  

743.0

  

192.7

  

-190.3

  

4,478.9

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

151.1

  

112.9

  

17.2

  

0.1

  

-95.9

  

-73.1

  

2.0

  

114.3

Depreciation and impairments / write-ups

  

79.1

  

34.9

  

6.4

  

233.8

  

122.4

  

87.8

  

–

  

564.4

EBITDA

  

230.2

  

147.8

  

23.6

  

233.9

  

26.5

  

14.7

  

2.0

  

678.7

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Result from investments in joint ventures and associates

  

5.9

  

–

  

–

  

–

  

-42.5

  

–

  

0.5

  

-36.1

Impairment losses

  

–

  

–

  

–

  

-1.4

  

-34.8

  

-0.8

  

–

  

-37.0

Additions to property, plant and equipment1

  

85.4

  

36.8

  

10.2

  

290.0

  

30.9

  

50.4

  

–

  

503.7

Asset additions

  

85.4

  

36.8

  

10.2

  

290.0

  

30.9

  

50.4

  

–

  

503.7

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,186.9

  

481.2

  

116.1

  

2,331.9

  

1,095.6

  

1,500.4

  

-379.7

  

6,332.4

Liabilities (Dec. 31)

  

691.8

  

280.6

  

60.7

  

1,809.4

  

302.8

  

1,365.4

  

-375.4

  

4,135.3

Net assets (Dec. 31)

  

495.1

  

200.6

  

55.4

  

522.5

  

792.8

  

135.0

  

-4.3

  

2,197.1

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Investments in joint ventures and associates included in net assets (Dec. 31)

  

18.9

  

–

  

–

  

–

  

–

  

–

  

–

  

18.9

Research and development expenses

  

34.6

  

12.3

  

7.0

  

20.6

  

59.2

  

43.4

  

-3.3

  

173.8

Employees (Dec. 31)

  

4,109

  

1,377

  

371

  

2,102

  

3,746

  

4,304

  

–

  

16,009

Employees (average)

  

4,110

  

1,377

  

371

  

2,126

  

3,806

  

4,344

  

–

  

16,134